Tardive Syndrome Is a Mysterious Phenomenon with Different Clinical Manifestations-Review.
clinical manifestation
management
physiopathology
tardive syndrome
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
14 Feb 2023
14 Feb 2023
Historique:
received:
05
12
2022
revised:
06
02
2023
accepted:
10
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
Tardive syndrome (TS) refers to persistent hyperkinetic, hypokinetic, and sensory complaints appearing after chronic neuroleptics and other dopamine receptor-blocking agents (DRBAs). It is defined as involuntary movements, often rhythmic, choreiform, or athetoid, involving the tongue, face, extremities, and sensory urges such as akathisia and lasts for a few weeks. TS develops in association with neuroleptic medication usage for a few months at least. There is usually a delay between the initiation of the causative drug and the onset of abnormal movements. However, it was soon noted that TS can also develop early, even days or weeks after DRBAs begin. However, the longer the exposure, the greater the risk of developing TS. Tardive dyskinesia, dystonia, akathisia, tremor, and parkinsonism are frequent phenomenologies of this syndrome.
Identifiants
pubmed: 36836033
pii: jcm12041498
doi: 10.3390/jcm12041498
pmc: PMC9967615
pii:
doi:
Types de publication
Editorial
Langues
eng
Références
Am J Psychiatry. 1989 Jun;146(6):802
pubmed: 2729434
Mov Disord. 1989;4(2):157-75
pubmed: 2567492
Neurology. 1994 Nov;44(11):2115-9
pubmed: 7969969
Brain. 1998 Nov;121 ( Pt 11):2053-66
pubmed: 9827766
Rev Neurol (Paris). 1959 Jun;100:751-5
pubmed: 14446619
Mov Disord. 2002 May;17(3):620-1
pubmed: 12112224
Arch Gen Psychiatry. 1982 Apr;39(4):486-7
pubmed: 6121550
J Neurol Sci. 2018 Jun 15;389:10-16
pubmed: 29433810
PLoS One. 2013 Aug 15;8(8):e71034
pubmed: 23967150
CNS Spectr. 2016 Dec;21(S1):13-24
pubmed: 28044943
Am J Psychiatry. 1990 Apr;147(4):445-51
pubmed: 1969244
Neurology. 1997 Feb;48(2):358-62
pubmed: 9040721
Neurology. 1978 Oct;28(10):1064-6
pubmed: 284201
Neuroscience. 2017 Oct 11;361:43-57
pubmed: 28790021
Mov Disord. 1998 May;13(3):486-9
pubmed: 9613742
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):507-9
pubmed: 18022743
J Clin Psychopharmacol. 2020 Jan/Feb;40(1):38-45
pubmed: 31834084
Mov Disord. 2020 May;35(5):752-755
pubmed: 32067258
Neurology. 1982 Dec;32(12):1335-46
pubmed: 6128697
Clin Neuropharmacol. 2015 Jan-Feb;38(1):23-5
pubmed: 25580924
Mov Disord. 1995 Mar;10(2):235-7
pubmed: 7753075
J Neurol Sci. 2018 Jun 15;389:67-75
pubmed: 29454493
Neurol Ther. 2018 Dec;7(2):233-248
pubmed: 30027457
Med Hypotheses. 2020 Mar 16;140:109682
pubmed: 32200182
Am J Psychiatry. 1999 Aug;156(8):1279-81
pubmed: 10450276
Neurologia. 1996 Jan;11(1):10-5
pubmed: 8714170
Mov Disord. 1992;7(1):53-7
pubmed: 1348352
Lancet. 1987 Feb 7;1(8528):322
pubmed: 2880125
Parkinsonism Relat Disord. 2017 Aug;41:58-65
pubmed: 28552340
J Clin Psychiatry. 2017 Mar;78(3):e279-e285
pubmed: 28199071
Mov Disord. 1997 Sep;12(5):808-10
pubmed: 9380072
Rev Neurol (Paris). 1994 Nov;150(11):757-62
pubmed: 7597368
Can J Psychiatry. 2002 Feb;47(1):27-38
pubmed: 11873706
Mov Disord. 2013 Feb;28(2):210-5
pubmed: 23280482
Cochrane Database Syst Rev. 2018 Feb 06;2:CD000459
pubmed: 29409162
Br J Psychiatry. 2013 Jul;203(1):51-7
pubmed: 23222039
Arch Neurol. 1982 Oct;39(10):644-6
pubmed: 6127066
Neurology. 2016 Feb 16;86(7):651-9
pubmed: 26791148
Parkinsonism Relat Disord. 2014 Jul;20(7):738-42
pubmed: 24742370
Acta Psychiatr Scand. 1964;40(1):10-27
pubmed: 14217630
Int Pharmacopsychiatry. 1982;17(3):185-92
pubmed: 6128331
J Clin Psychiatry. 2008 Apr;69(4):546-54
pubmed: 18312060
Tremor Other Hyperkinet Mov (N Y). 2013 Jul 12;3:
pubmed: 23858394
Am J Psychiatry. 1956 Aug;113(2):115-21
pubmed: 13340010